resources

Emcure Pharmaceuticals Ltd.

NSE: EMCURE

BSE: 544210

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

1,770.40-12.2 (-0.68%)

23 Oct, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Emcure Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2024	2025	2026
Annual Reports	—	FY 2025	FY 2026
Quarterly Results	Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	19Aug 13Nov	11Feb 28May 13Aug 17Nov	10Feb 11May 12Aug
Presentations	—	19Nov	20Feb 5May 12Jun 6Aug 25Sept

Corporate Announcements and Regulatory Filings

Emcure Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Analyst / Investor Meet14 Oct 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation for Earnings Call - Q2 FY27
Board Meeting14 Oct 2026
Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half-Year Ended September 30, 2026
Emcure Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Unaudited Financial ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201812 Oct 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Confirmation under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026
Scheme of Arrangement12 Oct 2026
Announcement under Regulation 30 (LODR)-Scheme of Arrangement
Proposed Scheme of Amalgamation of Zuventus Healthcare Limited and Emcutix Biopharmaceuticals Limited, wholly owned subsidiaries of the Company with Emcure Pharmaceuticals Limited - Holding ....
Award of Order / Receipt of Order2 Oct 2026
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Regulatory Order(s)
Closure of Trading Window29 Sept 2026
Closure of Trading Window
Intimation of Closure of Trading Window
General23 Sept 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulations, 2015 - Change In Composition Of The Board Of The Company
Change in composition of the Board of the Company
AGM23 Sept 2026
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results of the 45th Annual General Meeting of the Company along with the consolidated Report of the Scrutinizer
AGM21 Sept 2026
Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of the 45th Annual General Meeting of the Members of the Company
Allotment of ESOP / ESPS11 Sept 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 11,400 Equity Shares pursuant to exercise of ESOPs under Emcure - Employee Stock Option Scheme 2013
General1 Sept 2026
Intimation Under Regulations 30 And 36(1)(B) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Dispatch of letter to the members whose e-mail addresses are not registered with the Company/Depository Participants
Analyst / Investor Meet1 Sept 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of schedule of Investor Meet on Friday, September 04, 2026
Credit Rating1 Sept 2026
Announcement under Regulation 30 (LODR)-Credit Rating
Reaffirmation of Credit Ratings by CARE Ratings Limited
Newspaper Publication29 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement of Notice of the 45th Annual General Meeting and e-voting information
Business Responsibility and Sustainability Reporting (BRSR)28 Aug 2026
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Report for the Financial Year 2025-26
AGM28 Aug 2026
Notice Of The 45Th Annual General Meeting
Notice of the 45th Annual General Meeting of Emcure Pharmaceuticals Limited
Reg. 34 (1) Annual Report28 Aug 2026
Reg. 34 (1) Annual Report.
Annual Report of the Company for the Financial Year 2025-26
Allotment of ESOP / ESPS25 Aug 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 19,100 Equity Shares pursuant to exercise of ESOPs under Emcure - Employee Stock Option Scheme 2013
Analyst / Investor Meet12 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of Earnings Call - Q1 FY27
General8 Aug 2026
Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Update on USFDA inspection at our formulations facility located at Sanand, Ahmedabad, Gujarat, India

Frequently Asked Questions

Where can I download the annual report of Emcure Pharmaceuticals Ltd.?

Annual reports of Emcure Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Emcure Pharmaceuticals Ltd.?

Quarterly earnings results and presentations of Emcure Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Emcure Pharmaceuticals Ltd. publish earnings call transcripts?

Earnings call transcripts of Emcure Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Emcure Pharmaceuticals Ltd.?

Investor presentations and annual day presentations of Emcure Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Emcure Pharmaceuticals Ltd.?

Corporate announcements and regulatory filings of Emcure Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Emcure Pharmaceuticals Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Emcure Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Emcure Pharmaceuticals Ltd.?

The ISIN (International Securities Identification Number) of Emcure Pharmaceuticals Ltd. is INE168P01015. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Emcure Pharmaceuticals Ltd. listed?

Emcure Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is EMCURE and the BSE code is -.

Where can I find the shareholding pattern of Emcure Pharmaceuticals Ltd.?

The quarterly shareholding pattern of Emcure Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Emcure Pharmaceuticals Ltd. on Sharpely?

Share price data for Emcure Pharmaceuticals Ltd. is updated as of 23 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.